Therapixel announces launch of prospective study on the utility of Artificial Intelligence (AI) as part of second reading breast cancer screening mammograms

The first French prospective clinical study to evaluate the contribution of AI in the second reading of screening mammograms.

0 Comments8 Minutes

Therapixel releases a new version of MammoScreen® that leverages prior exams for better accuracy

For the first time, an AI-based decision support software for breast cancer detection uses patient’s prior exams to refine its prediction of malignancy

0 Comments4 Minutes

Therapixel announces close of 15 M€ series B financing to deploy MammoScreen® 2D/3D

The Company will accelerate the commercial deployment of its Artificial Intelligence reading solution for 2D/3D mammography, with a focus on the United States

0 Comments11 Minutes

Therapixel receives FDA clearance for use of its AI-based breast cancer screening software MammoScreen® on Digital Breast Tomosynthesis

AI-powered reading aid for screening 2D & 3D mammography improves Radiologists’ performance in cancer detection

0 Comments4 Minutes

Come & meet us at the Journées Francophones de Radiologie

Therapixel exhibits at the JFR 2019. Come by our booth #138 to learn how to improve accuracy of breast cancer screening with our AI Software.

0 Comments1 Minutes

Therapixel runs against breast cancer

Therapixel ran ODYSSEA marathon to support the fight against breast cancer. We are honored to participate in Breast Cancer Awareness campaign!

0 Comments2 Minutes


October 3-5, 2019 Budapest, Hungary / Booth 20

0 Comments1 Minute